In vivo anti-tumor effect of tumor cell-derived exosomes combined with BCG

YANG Yun-shan,ZHONG Hai-jun,XIU Fang-ming,CAI Zhi-jian
DOI: https://doi.org/10.3872/j.issn.1007-385X.2009.03.011
2009-01-01
Abstract:Objective:To study the in vivo anti-tumor effect of exosomes (Exo) combined with bacillus Calmette-Guérin vaccine(BCG). Methods:Exo was isolated and purified from culture supernatant of E.G7-OVA tumor cells by density gradient centrifugation. Protein components of Exo were detected by Western blotting. Exo,BCG,Exo combined with BCG (Exo+BCG) or PBS were pre-injected into mice before injection of E.G7-OVA cells,and the anti-tumor effects were observed in each group. Mouse model bearing E.G7-OVA cells was established to examine the immuno-therapy effects of Exo with or without BCG. Cytotoxity of spleen CTL was measured by LDH in different groups. Results:Exo derived from E.G7-OVA cells contained HSP60,OVA,HSC70 and CD63 as detected by Western blotting. Tumor-free rate at 90 d was significantly higher in Exo+BCG vaccinated mice than those in Exo or BCG vaccinated mice as measured by immuno-protective assay (60% vs 20% or 0%,P<0.01). Immuno-therapy assay showed that tumor inhibitory effect in Exo+BCG group was significantly higher than those in Exo or BCG groups (P<0.01). CTL results showed that CTL of Exo+BCG vaccinated mice had significantly enhanced ability to specifically kill target E.G7-OVA cells compared with those of Exo and BCG groups (P<0.01). Conclusion:BCG as an immuno-adjuvant can significantly enhance the anti-tumor effect of exosomes in vivo.
What problem does this paper attempt to address?